ArticleJournal for immunotherapy of cancer2018

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.

Priyanka C Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.